Literature DB >> 12149318

Role of the laboratory in the diagnosis of enterohemorrhagic Escherichia coli infections.

Sue C Kehl1.   

Abstract

Entities:  

Mesh:

Year:  2002        PMID: 12149318      PMCID: PMC120634          DOI: 10.1128/JCM.40.8.2711-2715.2002

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


× No keyword cloud information.
  29 in total

1.  Comparison of sorbitol MacConkey agar and a two-step method which utilizes enzyme-linked immunosorbent assay toxin testing and a chromogenic agar to detect and isolate enterohemorrhagic Escherichia coli.

Authors:  T J Novicki; J A Daly; S L Mottice; K C Carroll
Journal:  J Clin Microbiol       Date:  2000-02       Impact factor: 5.948

2.  Evaluation of the VTEC-Screen "Seiken" test for detection of different types of Shiga toxin (verotoxin)-producing Escherichia coli (STEC) in human stool samples.

Authors:  Lothar Beutin; Sonja Zimmermann; Kerstin Gleier
Journal:  Diagn Microbiol Infect Dis       Date:  2002-01       Impact factor: 2.803

3.  The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.

Authors:  C S Wong; S Jelacic; R L Habeeb; S L Watkins; P I Tarr
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

Review 4.  Shiga and Shiga-like toxins.

Authors:  A D O'Brien; R K Holmes
Journal:  Microbiol Rev       Date:  1987-06

5.  Comparison of Escherichia coli O157:H7 antigen detection in stool and broth cultures to that in sorbitol-MacConkey agar stool cultures.

Authors:  J R Stapp; S Jelacic; Y L Yea; E J Klein; M Fischer; C R Clausen; X Qin; D L Swerdlow; P I Tarr
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

6.  Hemolytic-Uremic Syndrome and Escherichia coli O121 at a Lake in Connecticut, 1999.

Authors:  T A McCarthy; N L Barrett; J L Hadler; B Salsbury; R T Howard; D W Dingman; C D Brinkman; W F Bibb; M L Cartter
Journal:  Pediatrics       Date:  2001-10       Impact factor: 7.124

7.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

8.  Sporadic cases of haemolytic-uraemic syndrome associated with faecal cytotoxin and cytotoxin-producing Escherichia coli in stools.

Authors:  M A Karmali; B T Steele; M Petric; C Lim
Journal:  Lancet       Date:  1983-03-19       Impact factor: 79.321

9.  Hemorrhagic colitis associated with a rare Escherichia coli serotype.

Authors:  L W Riley; R S Remis; S D Helgerson; H B McGee; J G Wells; B R Davis; R J Hebert; E S Olcott; L M Johnson; N T Hargrett; P A Blake; M L Cohen
Journal:  N Engl J Med       Date:  1983-03-24       Impact factor: 91.245

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  19 in total

1.  Comparison of a commercial reversed passive latex agglutination assay to an enzyme immunoassay for the detection of Shiga toxin-producing Escherichia coli.

Authors:  K C Carroll; K Adamson; K Korgenski; A Croft; R Hankemeier; J Daly; C H Park
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2003-10-23       Impact factor: 3.267

2.  Rapid and sensitive detection of Shiga toxin-producing Escherichia coli from nonenriched stool specimens by real-time PCR in comparison to enzyme immunoassay and culture.

Authors:  Thomas E Grys; Lynne M Sloan; Jon E Rosenblatt; Robin Patel
Journal:  J Clin Microbiol       Date:  2009-05-13       Impact factor: 5.948

3.  Point: Should all stools be screened for Shiga toxin-producing Escherichia coli?

Authors:  Mario J Marcon
Journal:  J Clin Microbiol       Date:  2011-05-04       Impact factor: 5.948

4.  Specificity of PCR and serological assays in the detection of Escherichia coli Shiga toxin subtypes.

Authors:  Peter C H Feng; Karen Jinneman; Flemming Scheutz; Steven R Monday
Journal:  Appl Environ Microbiol       Date:  2011-07-29       Impact factor: 4.792

5.  Bovine feces from animals with gastrointestinal infections are a source of serologically diverse atypical enteropathogenic Escherichia coli and Shiga toxin-producing E. coli strains that commonly possess intimin.

Authors:  Michael A Hornitzky; Kim Mercieca; Karl A Bettelheim; Steven P Djordjevic
Journal:  Appl Environ Microbiol       Date:  2005-07       Impact factor: 4.792

6.  Shiga toxin-producing Escherichia coli in children: diagnosis and clinical manifestations of O157:H7 and non-O157:H7 infection.

Authors:  Christina R Hermos; Marcie Janineh; Linda L Han; Alexander J McAdam
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

7.  Usability and performance of CHROMagar STEC medium in detection of Shiga toxin-producing Escherichia coli strains.

Authors:  Jari J Hirvonen; Anja Siitonen; Suvi-Sirkku Kaukoranta
Journal:  J Clin Microbiol       Date:  2012-08-29       Impact factor: 5.948

8.  Evaluation of performance and potential clinical impact of ProSpecT Shiga toxin Escherichia coli microplate assay for detection of Shiga Toxin-producing E. coli in stool samples.

Authors:  Patrick J Gavin; Lance R Peterson; Anna C Pasquariello; Joanna Blackburn; Mark G Hamming; Kuo J Kuo; Richard B Thomson
Journal:  J Clin Microbiol       Date:  2004-04       Impact factor: 5.948

9.  Serotypes and virulence gene profiles of shiga toxin-producing Escherichia coli strains isolated from feces of pasture-fed and lot-fed sheep.

Authors:  Steven P Djordjevic; Vidiya Ramachandran; Karl A Bettelheim; Barbara A Vanselow; Peter Holst; Graham Bailey; Michael A Hornitzky
Journal:  Appl Environ Microbiol       Date:  2004-07       Impact factor: 4.792

10.  Serotypes, virulence genes, and intimin types of Shiga toxin (verotoxin)-producing Escherichia coli isolates from human patients: prevalence in Lugo, Spain, from 1992 through 1999.

Authors:  J E Blanco; M Blanco; M P Alonso; A Mora; G Dahbi; M A Coira; J Blanco
Journal:  J Clin Microbiol       Date:  2004-01       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.